Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/1/1996
1.
Phase II Randomized, Double-Blind Study of RMP-7 (A Bradykinin Analogue) plus CBDCA vs CBDCA/Placebo for Recurrent Malignant Glioma (Summary Last Modified 03/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
ALK-01-017
DFCI-95066, NCI-V95-0789
Last Modified:
8/1/1996
2.
Phase II Study of RMP-7 (a Bradykinin Analogue) plus CBDCA Administered Intra-Arterially for Recurrent Malignant Glioma (Summary Last Modified 08/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
YALE-HIC-8729
NCI-V96-0884
Last Modified:
5/18/2007
 
First Published:
5/1/1998
3.
Phase II Study of Lobradimil and Carboplatin in Patients With Recurrent or Refractory Childhood Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
21 and under at diagnosis
NCI
NCI-98-C-0074H
CCG-09716, ALK-01-041, NCI-T98-0011, COG-C09716, T98-0011, NCT00019422
Last Modified:
5/8/2006
4.
Phase I Study of RMP-7 (a Bradykinin Analogue) and Carboplatin for Refractory Childhood Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
21 and under
NCI, Pharmaceutical / Industry
ALK-01-036
NCI-96-C-0068C
Last Modified:
10/31/2007
 
First Published:
5/1/2000
5.
Phase I Study of Lobradimil Plus Carboplatin With Radiotherapy in Patients With Newly Diagnosed Brain Stem Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Temporarily closed
3 to 21
NCI
COG-ADVL0012
CCG-ADVL0012, ALK-01-042, CCG-09802, NCT00005602, ADVL00012
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute